Presented in partnership with Friends in the City (FitC). Attend in person or attend the online webinar. This presentation explores the role of lifestyle, exercise, genetics and biology in the genesis of Alzheimer's and vascular dementia. Learn how medications may help prevent the downslide into dementia if Alzheimer's disease is diagnosed in the early stage of mild cognitive impairment. And find out how to be screened to join a cutting edge, global clinical trial which is seeking treatments for Alzheimer's disease. Cherian Verghese, MD, MRCPsych (UK), is the Principal Investigator at Keystone Clinical Studies, Norristown, PA and Assistant Professor of Psychiatry at Temple University. With a background in academic psychiatric research, he is a Key Opinion Leader in the field of drug development for psychiatric disorders and novel psychiatric medications. To register for the online webinar or receive a recording later: http://bit.ly/dementiaVigR Tuesday, May 1, 2018: Noon - 1:00 p.m.   To attend in person: Tuesday, April 24, 2018: 1:30 pm. - 3:00 p.m.